Risk Factors Update Summary
- Added risks from high inflationary environments and rising interest rates, including the impact of the war in Ukraine and escalation of the conflict in the Middle East.
- Geopolitical tensions between the United States and China increased, resulting in a 10% decrease in net sales in China during 2023.
- Increased focus on domestic purchasing requirements in China, leading to reduced foreign investment and demand.
- Market demand decline in core segments like pharma/biopharmaceutical, food manufacturing, and chemical industries, impacting net sales.
- Potential risks from ongoing and future impacts of global conflicts, such as the Israel-Hamas war, on economic and geopolitical uncertainty.
- Adoption of new regulations around AI and machine learning tools could impact product launches and compliance efforts.
- Replacement of LIBOR with SOFR in credit agreements, with no material impact on financial statements.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=1037646&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.